"Here's What This Huge Money-Manager Has Been Buying and Selling"
""Every quarter, many money managers have to disclose what they've bought and sold via 13F filings. Their latest moves can shine a bright light on smart stock picks.
Today let's look at Columbia Wanger Asset Management. Founded in 1992, it's a subsidiary of Ameriprise Financial, managing mutual funds and serving investment companies, pension plans, and others. Its reportable stock portfolio totaled $26.1 billion in value as of Dec. 31, 2013.
So what does Columbia Wanger's latest quarterly 13F filing tell us? Here are a few interesting details:
The biggest new holdings are aerospace simulation specialist CAE and Groupon, Inc. Other new holdings of interest include Celldex Therapeutics (NASDAQ: CLDX ) and RE/MAX Holdings (NYSE: RMAX ) . Celldex shares more than tripled over the past year, making it one of 2013's best-performing biotechs, largely because of excitement over its late-stage brain cancer immunotherapy treatment, rindopepimut. The company has seen great promise in some of its formulations, with more in its pipeline. Cash burn, addressed via stock dilution, has been a concern, but with biotech companies, potential FDA approvals are the keys to ultimate success, and additional stock issuances aren't necessarily regrettable.""
Technically in this down market over the last 10 days Celdex holding close above that 25 level like a champ
Looks like it wants to go higher into the Feb Conference-a move over 28 will yield 30+ test